120 related articles for article (PubMed ID: 15154997)
1. Preliminary experience with nesiritide in the pediatric population.
Marshall J; Berkenbosch JW; Russo P; Tobias JD
J Intensive Care Med; 2004; 19(3):164-70. PubMed ID: 15154997
[TBL] [Abstract][Full Text] [Related]
2. Preliminary experience with nesiritide in pediatric patients less than 12 months of age.
Ryan A; Rosen DA; Tobias JD
J Intensive Care Med; 2008; 23(5):321-8. PubMed ID: 18603536
[TBL] [Abstract][Full Text] [Related]
3. Nesiritide during extracorporeal membrane oxygenation.
Smith T; Rosen DA; Russo P; Berkenbosch JW; Gustafson RA; Siu BL; Rosen KR; Tobias JD
Paediatr Anaesth; 2005 Feb; 15(2):152-7. PubMed ID: 15675934
[TBL] [Abstract][Full Text] [Related]
4. Nesiritide in a pediatric oncology patient with renal insufficiency and myocardial dysfunction following septic shock.
Wheeler AD; Tobias JD
Pediatr Hematol Oncol; 2005 Jun; 22(4):323-33. PubMed ID: 16020120
[TBL] [Abstract][Full Text] [Related]
5. Nesiritide use in pediatric patients with congestive heart failure.
Feingold B; Law YM
J Heart Lung Transplant; 2004 Dec; 23(12):1455-9. PubMed ID: 15607680
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of nesiritide in pediatric heart failure.
Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA
J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644
[TBL] [Abstract][Full Text] [Related]
7. Perioperative effects and safety of nesiritide following cardiac surgery in children.
Simsic JM; Scheurer M; Tobias JD; Berkenbosch J; Schechter W; Madera F; Weinstein S; Michler RE
J Intensive Care Med; 2006; 21(1):22-6. PubMed ID: 16698741
[TBL] [Abstract][Full Text] [Related]
8. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Aronson D; Burger AJ
Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
[TBL] [Abstract][Full Text] [Related]
9. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of nesiritide for the treatment of decompensated heart failure.
Emerman CL
Rev Cardiovasc Med; 2002; 3 Suppl 4():S28-34. PubMed ID: 12439428
[TBL] [Abstract][Full Text] [Related]
11. Administration of a large nesiritide bolus dose in a pediatric patient: case report and review of nesiritide use in pediatrics.
Moffett BS; Jefferies JL; Price JF; Clunie S; Denfield S; Dreyer WJ; Towbin JA
Pharmacotherapy; 2006 Feb; 26(2):277-80. PubMed ID: 16466333
[TBL] [Abstract][Full Text] [Related]
12. Nesiritide therapy in a term neonate with renal disease.
Moffett BS; Jefferies JL; Rossano J; Towbin JA
Pharmacotherapy; 2006 Feb; 26(2):281-4. PubMed ID: 16466334
[TBL] [Abstract][Full Text] [Related]
13. Nesiritide for the treatment of decompensated heart failure.
Wylie JV; Tsao L
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
[TBL] [Abstract][Full Text] [Related]
14. Administration of nesiritide in patients after coronary artery bypass surgery induces brisk diuresis.
Benharash P; Omari B
Am Surg; 2005 Sep; 71(9):794-6. PubMed ID: 16468521
[TBL] [Abstract][Full Text] [Related]
15. Nesiritide: past, present, and future.
Burger AJ; Burger MR
Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
[TBL] [Abstract][Full Text] [Related]
16. A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children.
Costello JM; Goodman DM; Green TP
Pediatr Crit Care Med; 2006 Jul; 7(4):308-18. PubMed ID: 16760825
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).
Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM
Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633
[TBL] [Abstract][Full Text] [Related]
18. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients.
Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA
Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834
[TBL] [Abstract][Full Text] [Related]
19. Intermittent outpatient nesiritide infusion reduces hospital admissions in patients with advanced heart failure.
Schwarz ER; Najam S; Akel R; Sulimanjee N; Bionat S; Rosanio S
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):232-6. PubMed ID: 17875951
[TBL] [Abstract][Full Text] [Related]
20. A prospective evaluation of nesiritide in the treatment of pediatric heart failure.
Jefferies JL; Denfield SW; Price JF; Dreyer WJ; McMahon CJ; Grenier MA; Kim JJ; Dimas VV; Clunie SK; Moffett BS; Chang AC; Wann TI; Smith EO; Towbin JA
Pediatr Cardiol; 2006; 27(4):402-7. PubMed ID: 16830089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
